- Neural plasticity
- Neuronal impulses
Compared to other cells, except neural cells, the biggest property of neural cells is to have a particular electrical activity in each cell itself. The activity that shows a specific pattern will carry different information as a history of each neural cell. At present, we have examined the roles of neural impulses and revealed that a synaptic plasticity can be controlled by different patterned neural acitivites, such as different frequencies or oscillation patterns. Even though neural cells have similar genetic backgrounds, different environments give cells different neural activities and finally different characters of cells. Current studies have revealed that a particular pattern of neural activity, e.g. frequency, could be effective in some diseases. In response to environmental changes occurring throughout development and adult life, the brain reorganizes itself by adjusting the pattern of activity. In some cases, a particular pattern of neural acitivity decides the neural fate and should be able to control brain function even in higher functions. In the future, in order to understand the role of activity patterns and mechanisms of fundamental information processing in the brain, it will be necessary that the meaning of patterns is explained from molecular, biological and morphological perspectives, i.e., not only with metaphysical ‘phenomena’, but also at a physical ‘material’ level.
Copyright © 2002 S. Karger AG, Basel
- Hall Z, Bloom FE, Fischbach G: Introduction. Where neuroscience has been and where it needs to go. Neurobiol Dis 2000;7:495–498.
- Bodybuilding: The bionic human (review). Science 2002;295:995–1033.
- Buonanno A, Fields RD: Gene regulation by patterned electrical activity during neural and skeletal muscle development. Curr Opin Neurobiol 1999;9:110–120.
- Ozaki M: Neuregulins and the shaping of synapses. Neuroscientist 2001;7:146–156.
- Du J, Feng L, Yang F, Lu B: Activity- and Ca2+-dependent modulation of surface expression of brain-derived neurotrophic factor receptors in hippocampal neurons. J Cell Biol 2000;150:1423–1434.
- Itoh K, Ozaki M, Steven B, Fields RD: Activity-dependent regulation of N-cadherin in DRG neurons: Differential regulation of N-cadherin, NCAM, and L1 by distinct patterns of action potentials. J Neurobiol 1997;33:735–748.
- Loeb JA, Hmadcha A, Fischbach GD, Land SJ, Zakarian VL: Neuregulin expression at neuromuscular synapses is modulated by synaptic activity and neurotropic factors. J Neurobiol 2002;22:2206–2214.
- Cameron JS, Dryer L, Dryer S: β-Neuregulin-1 is required for the in vivo development of functional Ca2+-activated K+ channels in parasympathetic neurons. Proc Natl Acad Sci USA 2001;98:2832–2836.
- Zhu JJ, Esteban JA, Hayashi Y, Malinow R: Postnatal synaptic potentiation: Delivery of GluR4-containing AMPA receptors by spontaneous activity. Nat Neurosci 2000;11:1098–1106.
- Pierre K, Dupouy B, Allard M, Poulain DA, Theodosis DT: Mobilization of the cell adhesion glycoprotein F3/contactin to axonal surfaces is activity dependent. Eur J Neurosci 2001;14:645–656.
- Ozaki M, Itoh K, Miyakawa Y, Kishida H, Hashikawa T: Neuregulin protein processing is regulated in a frequency-dependent manner (abstract). 32nd Annual Meeting of the Society for Neuroscience, Orlando, Fla. 2002.
- Colicos MA, Collins BE, Sailor MJ, Goda Y: Remodeling of synaptic actin induced by photoconductive stimulation. Cell 2001;107:605–616.
- Inokuchi K: Regulation of gene expression and RNA splicing during long-term potentiation (abstract). 24th Annual Meeting of the Society of Japanese Molecular Biology, Yokohama, Japan, 2001.
- Nicolaidis SC, Williams HB: Muscle preservation using an implantable electrical system after nerve injury and repair. Microsurgery 2001;21:241–247.
- Raineteau O, Schwab ME: Plasticity of motor systems after incomplete spinal cord injury. Nat Rev Neurosci 2001;4:263–273.
- Sadowsky CL: Electrical stimulation in spinal cord injury. NeuroRehabilitation 2001;16:165–169.
- Somia NN, Zonnevijlle ED, Stremel RW, Maldonado C, Gossman MD, Barker JH: Multi-channel orbicularis oculi stimulation to restore eye-blink function in facial paralysis. Microsurgery 2001;21:264–270.
- Jacobs MP, Fischbach GD, Davis MR, Dichter MA, Dingledine R, Lowenstein DH, Morrell MJ, Noebels JL, Rogawski MA, Spencer SS, Theodore WH: Future directions for epilepsy research. Neurology 2001;57:1536–1542.
- Chitoku S, Otsubo H, Harada Y, Jay V, Rutka JT, Weiss SK, Abdoll M, Snead OC 3rd: Extraoperative cortical stimulation of motor function in children. Pediatr Neurol 2001;24:344–350.
- Eskandar EN, Cosgrove GR, Shinobu LA: Surgical treatment of Parkinson disease. JAMA 2001;286:3056–3059.
- Humayun MS, de Juan E Jr, Weiland JD, Dagnelie G, Katona S, Greenberg R, Suzuki S: Pattern electrical stimulation of the human retina. Vision Res 1999;39:2569–2576.
- Buonanno A, Fischbach GD: Neuregulin and ErbB receptor signaling pathways in the nervous system. Curr Opin Neurobiol 2001;11:287–296.
- Huang YZ, Won S, Ali DW, Wang Q, Tanowitz M, Du QS, Pelkey KA, Yang DJ, Xiong WC, Salter MW, Mei L: Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses. Neuron 2000;26:443–455.
- Liu Y, Ford B, Mann MA, Fischbach GD: Neuregulins increase α7 nicotinic acetylcholine receptors and enhance excitatory synaptic transmission in GABAergic interneurons of the hippocampus. J Neurosci 2001;21:5660–5669.
- Wang JY, Wigston DJ, Rees HD, Levey AI, Falls DL: LIM kinase 1 accumulates in presynaptic terminals during synapse maturation. J Comp Neurol 2000;416:319–334.
- Huang YZ, Wang Q, Xiong WC, Mei L: Erbin is a protein concentrated at postsynaptic membranes that interacts with PSD-95. J Biol Chem 2001;276:19318–19326.
- Krainock R, Murphy S: Heregulin upregulates the expression of nitric oxide synthase (NOS)-1 in rat cerebellar granule neurons via the ErbB4 receptor. J Neurochem 2001;76:312–315.
- Krainock R, Murphy S: Regulation of functional nitric oxide synthase-1 expression in cerebellar granule neurons by heregulin is post-transcriptional, and involves mitogen-activated protein kinase. J Neurochem 2001;78:552–559.
- Murphy S, Krainock R, Tham M: Neuregulin signaling via ErbB receptor assemblies in the nervous system. Mol Neurobiol 2002;25:67–77.
- Hijazi MM, Thompson EW, Tang C, Coopman P, Torri JA, Yang D, Mueller SC, Lupu R: Heregulin regulates the actin cytoskeleton and promotes invasive properties in breast cancer cell lines. Int J Oncol 2000;17:629–641.
- Chausovsky A, Waterman H, Elbaum M, Yarden Y, Geiger B, Bershadsky AD: Molecular requirements for the effect of neuregulin on cell spreading, motility and colony organization. Oncogene 2000;19:878–888.
- Sheng M, Sala C: PDZ domains and the organization of supramolecular complexes. Annu Rev Neurosci 2001;24:1–29.
- Smith DS, Tsai LH: Cdk5 behind the wheel: A role in trafficking and transport? Trends Cell Biol 2002;12:28–36.
- Fu AKY, Fu WY, Cheung J, Tsim KWK, Ip FCF, Wang JH, Ip NY: Cdk5 is involved in neuregulin-induced AChR expression at the neuromuscular junction. Nat Neurosci 2001;4:374–381.
- Fields RD, Itoh K: Neural cell adhesion molecules in activity-dependent development and synaptic plasticity. Trends Neurosci 1996;19:449–526.
Miwako Ozaki, PhD
Laboratory for Neural Architecture, Brain Science Institute, RIKEN
Wako-shi, Saitama 351-0198 (Japan)
Tel. +81 48 462 1111, ext. 7264, Fax +81 48 467 5926
Number of Print Pages : 6
Number of Figures : 3, Number of Tables : 1, Number of References : 35
Founded 1992 as ‘Biological Signals’ by S.F. Pang (1992–2001) continued as ‘Biological Signals and Receptors’ (1999–2001)
Vol. 11, No. 4, Year 2002 (Cover Date: July-August 2002)
Journal Editor: Nancy Y. Ip, Hong Kong
ISSN: 1424–862X (print), 1424–8638 (Online)
For additional information: http://www.karger.com/journals/nsg
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.